Trials / Conditions / Primary Mediastinal Large B-Cell Lymphoma-Recurrent
Primary Mediastinal Large B-Cell Lymphoma-Recurrent
4 registered clinical trials studyying Primary Mediastinal Large B-Cell Lymphoma-Recurrent — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relap NCT06703892 | GenomeFrontier Therapeutics TW Co., Ltd. | Phase 1 |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alf NCT06504394 | Merck Sharp & Dohme LLC | Phase 2 |
| Recruiting | CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma NCT06209619 | Nathan Denlinger | Phase 1 |
| Recruiting | Pembro Plus CAR T-cell Therapy in R/R in PMBCL NCT05934448 | Jennifer Crombie, MD | Phase 2 |